AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2017
Apr 3, 2017
34395_dirs_2017-04-03_344f8f5a-50c5-402f-b6e2-a7f3b80035ae.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2017-03-30
Reporting Person: Rootsaert Rodney Gerard (Secretary)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-03-30 | Stock Option (Right to Buy) | $5 | A | 60000 | Acquired | 2023-03-30 | Common Stock (60000) | Direct |
Footnotes
F1: A total of 60,000 Options were granted on March 30, 2017 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant.